You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for NDC 78670-0130


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 78670-0130

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
SYMJEPI 0.3MG/0.3ML INJ,SYRINGE,0.3ML USWM, LLC 78670-0130-02 2 196.98 98.49000 2023-01-01 - 2026-02-14 FSS
SYMJEPI 0.3MG/0.3ML INJ,SYRINGE,0.3ML USWM, LLC 78670-0130-02 2 196.98 98.49000 2024-01-01 - 2026-02-14 FSS
SYMJEPI 0.3MG/0.3ML INJ,SYRINGE,0.3ML USWM, LLC 78670-0130-02 2 174.49 87.24500 2024-01-01 - 2026-02-14 Big4
SYMJEPI 0.3MG/0.3ML INJ,SYRINGE,0.3ML USWM, LLC 78670-0130-02 2 168.27 84.13500 2023-01-01 - 2026-02-14 Big4
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for the Drug NDC: 78670-0130

Understanding NDC Codes

To begin with, it is crucial to understand what an NDC (National Drug Code) is. An NDC is a unique 10-digit, 3-segment numerical code assigned to medications in the United States. It identifies the labeler, product, and trade package size of the drug[4].

Identifying the Drug

The NDC code 78670-0130 needs to be identified to understand the specific drug it represents. However, without direct access to a database or lookup tool at this moment, we can infer the importance of such a code in market analysis.

Market Analysis

Importance of NDC Codes in Market Analysis

NDC codes are vital for accurate billing, payment, and control of drug costs. They help in ensuring correct payment and save significant time and effort when verified correctly[4].

Drug Pricing Dynamics

The pricing of drugs, especially those with high demand and limited competition, can be highly volatile. For instance, the median price increase for generic drugs was reported to be 19.9% in 2022, with some drugs experiencing drastic increases, such as a 2,527% increase for a generic naproxen[2].

Regulatory Influences

Regulatory actions significantly impact drug prices. For example, the FDA's determination that certain drugs do not have approved applications can lead to their exclusion from rebate programs and affect their market presence[1].

Price Projections

Impact of Negotiated Prices

The Biden-Harris administration's efforts to negotiate lower prices for Medicare-covered drugs can significantly impact the market. For the first 10 drugs selected, negotiated prices are expected to cut list prices by 38% to 79%, resulting in substantial savings for Medicare beneficiaries[5].

Generic vs. Brand Name Drugs

Generic drugs often see higher price increases compared to brand name drugs. However, brand name drugs can also experience significant price reductions through negotiation. For instance, the negotiated price for Eliquis is expected to drop from $521 to $231 per 30-day supply, a 56% reduction[5].

Specific Projections for NDC: 78670-0130

Without specific data on the drug associated with NDC 78670-0130, it is challenging to provide precise price projections. However, here are some general considerations:

Historical Price Trends

If the drug is a generic, it might have experienced price increases similar to those reported in 2022. For example, a generic drug could see a median price increase of 19.9%[2].

Regulatory and Market Factors

If the drug is subject to FDA actions or market negotiations, its price could be significantly affected. For instance, if the drug is part of a negotiation program like Medicare's, it could see a reduction in list price similar to the drugs mentioned in the Biden-Harris administration's announcement[5].

Market Demand and Competition

The price of the drug would also be influenced by market demand and competition. High-demand drugs with limited competition tend to have higher prices and more volatile pricing dynamics.

Key Takeaways

  • NDC Codes: Critical for accurate billing and cost control.
  • Regulatory Impact: FDA actions and government negotiations can significantly affect drug prices.
  • Price Volatility: Generic drugs can experience high price increases, while negotiated prices for brand name drugs can result in substantial savings.
  • Market Dynamics: Demand and competition play crucial roles in determining drug prices.

FAQs

  1. What is an NDC code?

    • An NDC (National Drug Code) is a unique 10-digit code assigned to medications in the United States, identifying the labeler, product, and trade package size[4].
  2. How do regulatory actions affect drug prices?

    • Regulatory actions, such as FDA determinations and government negotiations, can lead to price reductions or exclusions from rebate programs, significantly impacting the market[1][5].
  3. What is the impact of negotiated prices on drug costs?

    • Negotiated prices, as seen in the Medicare drug price negotiation program, can reduce list prices by 38% to 79%, resulting in substantial savings for beneficiaries[5].
  4. Why are generic drugs experiencing high price increases?

    • Generic drugs often see higher price increases due to various market and regulatory factors, including supply chain issues and lack of competition[2].
  5. How does market demand influence drug prices?

    • High-demand drugs, especially those with limited competition, tend to have higher prices and more volatile pricing dynamics due to market forces[2][5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.